Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Decologne, G. Wettstein, C. Didelot, C. Garrido, P. Camus, P. Bonniaud (Dijon, France). Carbon nanoparticles (CN) are a dramatic trigger in the process of bleomycin-induced pleural and subpleural fibrosis. Eur Respir J 2008; 32: Suppl. 52, 715

Member's Comments

No comment yet.

Related content which might interest you: Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles Source: Eur Respir J 2010; 35: 176-185 Year: 2010 Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma Source: Eur Respir J 2009; 34: 559 Year: 2009 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Imatinib-loaded gold nanoparticles ameliorate experimental lung fibrosis induced by bleomycin Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017 Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta-mediated extracellular matrix protein production Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Mucus matters: Ferrets demonstrate sustained fibrosis and mucociliary decrement following bleomycin-induced pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Sulforaphane attenuates lung fibrosis in bleomycin-induced pulmonary fibrosis via inhibition of TGF-beta/Smad signaling Source: International Congress 2014 – ILDs 4 Year: 2014 Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP) Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 Treprostinil effectively inhibits PDGF and TGF-ß1 induced extracellular matrix composition by IPF fibroblasts Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Neutrophil extracellular traps contribute to pulmonary fibrosis induced by bleomycin Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Ectopic subpleural fat deposition in idiopathic pulmonary fibrosis correlates with radiographic extension of fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis Source: Eur Respir J 2012; 39: 546-557 Year: 2012 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013